The prevalence of hepatitis B in Sweden; A statistical serosurvey of 3381 Swedish inhabitants

被引:16
作者
Christenson, B
Bottiger, M
Grillner, L
机构
[1] SWEDISH INST INFECT DIS CONTROL,SE-10521 STOCKHOLM,SWEDEN
[2] KAROLINSKA HOSP,DEPT CLIN MICROBIOL,SE-17176 STOCKHOLM,SWEDEN
关键词
D O I
10.1017/S0950268897007838
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 [公共卫生与预防医学]; 120402 [社会医学与卫生事业管理];
摘要
The prevalence of hepatitis B virus markers in the adult Swedish population was investigated according to age, sex, origin and demographic stratum. Sera were collected from 3382 persons in 1990-1. The sera were selected on a statistical basis considered to be representative of the Swedish population from adults aged greater than or equal to 18 years. Two of the sera (0.06%) were found to be hepatitis B surface antigen positive. The two hepatitis B carriers were of non-Scandinavian origin as were (8.9%) of those tested. A total of 90 persons had a marker of previous, hepatitis B virus infection, i.e. antibodies against hepatitis B core antigen. Of these, 66 (2.0%) were of Scandinavian origin and 24 (18.1%) from highly endemic areas. The overall hepatitis B virus marker prevalence was 2.7%. The highest age-specific prevalence of hepatitis B markers in those of Scandinavian origin was in those born in 1939 and earlier. In this age-group, women had a significantly higher prevalence (3.6%) than males (1.9%). The lowest prevalence was found in those born in 1970 and later. No significant, age-related differences between younger or older persons, or between men and women, could be found in persons of non-Scandinavian origin. The results showed significant differences in exposure to hepatitis B virus among the indigenous population, compared with those of non-Scandinavian extraction. The results do not support the proposal to include hepatitis B vaccination in the Swedish immunization schedule.
引用
收藏
页码:221 / 225
页数:5
相关论文
共 16 条
[1]
BANKE O, 1971, LANCET, V1, P860
[3]
EPIDEMIOLOGY OF HEPATITIS-B IN SWEDEN [J].
CHRISTENSON, B .
JOURNAL OF INFECTION, 1987, 15 (03) :269-277
[4]
Christenson B, 1990, Lakartidningen, V87, P2745
[5]
OCCUPATIONAL EXPOSURE TO HEPATITIS-B VIRUS IN HOSPITAL PERSONNEL - INFECTION OR IMMUNIZATION [J].
DIENSTAG, JL ;
RYAN, DM .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1982, 115 (01) :26-39
[6]
HANSSON BG, 1976, ACTA PATH MICRO IM B, V84, P342
[7]
HEPATITIS-ASSOCIATED ANTIGEN AND ANTIBODY IN SWEDISH BLOOD DONORS - RELATION TO LIVER-DISEASE [J].
IWARSON, S ;
HERMODSSON, S ;
LINDHOLM, A ;
LUNDIN, P .
VOX SANGUINIS, 1972, 22 (06) :501-+
[8]
Global status of hepatitis B immunisation [J].
Kane, MA .
LANCET, 1996, 348 (9029) :696-696
[9]
HEPATITIS-B VACCINATION THE COST-EFFECTIVENESS OF ALTERNATIVE STRATEGIES IN ENGLAND AND WALES [J].
MANGTANI, P ;
HALL, AJ ;
NORMAND, CEM .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1995, 49 (03) :238-244
[10]
Norkrans G, 1983, Lakartidningen, V80, P3176